Cognitive Behavioral Therapy for Depression and Insulin Sensitivity in Adolescents
Trial Summary
What is the purpose of this trial?
There has been a rise in type 2 diabetes (T2D) rates in adolescents, disproportionately in girls from disadvantaged racial/ethnic groups. This group of girls also is at heightened risk for depression, and depression and T2D are linked. Depressive symptoms are a risk factor for worsening of insulin sensitivity, one if the major precursors to T2D. In preliminary studies, the investigators found that a brief cognitive-behavioral therapy group decreased depressive symptoms and prevented worsening of insulin sensitivity in adolescent girls at-risk for T2D with moderate depressive symptoms. The aims of this study are: 1) to assess the efficacy of a cognitive-behavioral therapy depression group vs. a health education control group for improving insulin sensitivity and preserving insulin secretion in racially/ethnically diverse adolescent girls at-risk for T2D with moderate depressive symptoms over a 1-year follow-up; 2) to evaluate changes in eating, physical activity, and sleep as explanatory and 3) to test changes in cortisol factors as explanatory.
Will I have to stop taking my current medications?
Yes, you will need to stop taking medications that affect mood, weight, cortisol, or insulin sensitivity, such as insulin sensitizers, anti-depressants, and stimulants.
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy for Depression and Insulin Sensitivity in Adolescents?
Research shows that Cognitive Behavioral Therapy (CBT) can help reduce depression symptoms, which is linked to improved insulin sensitivity in adolescents at risk for type 2 diabetes. Additionally, CBT has been effective in decreasing depression and improving related health outcomes like body mass index and insulin resistance.12345
Is Cognitive Behavioral Therapy (CBT) safe for adolescents?
Cognitive Behavioral Therapy (CBT) is generally considered safe for adolescents and is a well-established treatment for depression in this age group. It has been extensively tested and is one of the two evidence-based psychotherapies for adolescent depression, with no significant safety concerns reported in the studies reviewed.34678
How is cognitive-behavioral therapy (CBT) unique for treating depression and insulin sensitivity in adolescents?
Cognitive-behavioral therapy (CBT) is unique because it not only addresses depression in adolescents but also has the potential to improve insulin sensitivity, which is important for those at risk of type 2 diabetes. Unlike medications, CBT focuses on changing negative thought patterns and behaviors, making it a non-drug approach that can have long-term benefits for both mental and physical health.13489
Eligibility Criteria
Adolescent girls aged 12-17 with moderate depression and a high risk for type 2 diabetes are eligible. They must have a family history of diabetes, be English-speaking, and have a BMI in the top 15% for their age and sex. Girls who already have type 2 diabetes, are pregnant or breastfeeding, on certain medications affecting mood or insulin sensitivity, or suffering from major psychiatric disorders cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-week cognitive-behavioral therapy group or a health education control group, with weekly 1-hour sessions
Follow-up
Participants are monitored for changes in insulin sensitivity, depressive symptoms, and other secondary outcomes over a 1-year period
Treatment Details
Interventions
- Cognitive-behavioral therapy group (Behavioral)
- Health education group (Behavioral)